Alzheimer’s cure would result in assisted living losses of $16 billion in annual revenues, 110,000...
By
Lois A. Bowers
Sep 17, 2019
A “novel, simple and fast-acting” cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in annual revenues for the assisted living industry, according...
Flu vaccine tied to lower Alzheimer’s disease risk in older adults
Jul 26, 2022
Vaccination was associated with a 40% reduced risk for Alzheimer’s disease.
Two major health systems will not administer controversial Aduhelm
Jul 15, 2021
Individual doctors can prescribe Aduhelm, but patients would have to go elsewhere to receive the drug via infusion.
An Operation Warp Speed for Alzheimer’s? Why not?
By
John O'Connor
Jan 14, 2021
Our nation’s response to COVID-19 provides a definitive answer about what more can be done for Alzheimer’s disease.
Memory care will be big growth area in 2018, senior living leaders predict
By
Lois A. Bowers
Feb 14, 2018
Memory care will be the biggest growth area in senior living and long-term care in 2018, predict executives participating in Lancaster Pollard’s “2018 Seniors Housing and Care Survey,”...
Prevalence of LATE-NC explored in seniors, Alzheimer’s disease
Jun 20, 2022
Almost 40% of those with Alzheimer’s disease neuropathologic change had a limbic-predominant age-related TDP-43 encephalopathy neuropathologic change.
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
New CDC profile shares demographics of assisted living residents
By
Kimberly Bonvissuto
Sep 22, 2021
Bathing, walking and dressing are the most common activities of daily living that residents of assisted living or similar residential communities need help with, according to a new data brief from the...
FDA head asks for investigation into Alzheimer’s disease drug approval
Jul 12, 2021
The request follows reports that Biogen and the FDA held off-the-books meetings before the drug’s approval that may have violated FDA protocol.